Stocks and Investing Stocks and Investing
Wed, June 29, 2022
Tue, June 28, 2022
Mon, June 27, 2022
Fri, June 24, 2022

Etzer Darout Initiated (YMAB) at Buy and Held Target at $27 on, Jun 24th, 2022


Published on 2024-10-27 21:36:55 - WOPRAI, Etzer Darout
  Print publication without navigation


Etzer Darout of BMO Capital, Initiated "Y-mAbs Therapeutics, Inc." (YMAB) at Buy and Held Target at $27 on, Jun 24th, 2022.

Etzer has made no other calls on YMAB in the last 4 months.



There is 1 other peer that has a rating on YMAB. Out of the 1 peers that are also analyzing YMAB, 0 agree with Etzer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Etzer


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $63 on, Monday, February 28th, 2022